Beverly Hills Private Wealth’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
Beverly Hills Private Wealth's IBB Position: Q2 2026 in Review
Beverly Hills Private Wealth reduced its iShares Biotechnology ETF (IBB) stake by 5% in Q2 2026, selling an estimated $25.8K and leaving 2,821 shares worth $537K. The position accounts for 0.1% of the portfolio, ranked #152.
Beverly Hills Private Wealth first reported a position in IBB in Q4 2022 and has held it in 15 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Beverly Hills Private Wealth held 2,821 shares of iShares Biotechnology ETF worth $537K as of Q2 2026.
- Beverly Hills Private Wealth sold 150 iShares Biotechnology ETF shares in Q2 2026, an estimated $25.8K.
- iShares Biotechnology ETF made up 0.1% of Beverly Hills Private Wealth's portfolio in Q2 2026, its #152 holding.
- Beverly Hills Private Wealth first reported a position in iShares Biotechnology ETF in Q4 2022 and has held it in 15 quarters since.
- 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Beverly Hills Private Wealth's 13F filing for Q2 2026, filed 7 Aug 2026.